Accel Diagnostics

Complex Diagnoses Made Simple

Our pScreen™ device only requires a drop of body fluid, such as blood, saliva or urine. The highly sensitive immunoassay detects and quantifies biomarkers within minutes. It provides results that are comparable in accuracy to the ELISA and other laboratory-performed tests. Severe and chronic illnesses can be identified and monitored quickly and efficiently.

No sample preparation

Requires only a droplet of body fluid

No electricity or battery power needed

Accurate and sensitive biomarker
readings

Fully disposable, as compact as a
credit card

Results are ready in less than 20 minutes

Saving Time. Saving Money. Saving Recourses

The pScreen™ test stands apart from both laboratory tests and other point-of-care tests when it comes to convenience and cost. The technology does not require any electrical or battery power, nor does it require any additional supporting devices.

Everything needed to perform the test is inexpensive and disposable. Now, diagnostic tests can be performed anywhere: private practices, hospital rooms, clinics, in homes or out in the field. Patients with chronic illnesses can monitor their condition in the comfort of their own homes.

News and Updates

April 1, 2014

AccelDx is excited to be LivePitch Startup Finalist 2014 Health Innovation@50+

April 25, 2013

AccelDx receives Innovation Works funding

Oct 15, 2012

AccelDx introduces (follow link) pScreen-BNP for the diagnosis of heart failure at the In3 Medical Summit.

Sept 1, 2012

AccelDx receives $524,000 NIH sponsored SBIR

June 19, 2012

AccelDx's secures OFEF funding

Feb 3, 2012

AccelDx enters AlphaLab top ranking accelerator (follow link)

Dec 13, 2011

AccelDx signs the technology exclusive licensing agreement from Carnegie Mellon University

Oct 25, 2011

AccelDx receives funding through the Enterprise Creation Award from Carnegie Mellon to develop the Company beta prototype

Want to know more..